Celestica Q3 EPS $0.52 Misses $0.62 Estimate

Celestica (TSX:CLS) reported quarterly earnings of $0.52 per share which missed the analyst consensus estimate of $0.62 by 16.13 percent. This is a 48.57 percent increase over earnings of $0.35 per share from the same

Celestica (TSX:CLS) reported quarterly earnings of $0.52 per share which missed the analyst consensus estimate of $0.62 by 16.13 percent. This is a 48.57 percent increase over earnings of $0.35 per share from the same period last year.

Total
0
Shares
Related Posts
Read More

Blindness-Focused LENZ Therapeutics’ Investigational Eye Drop Ready To Revolutionize Presbyopia Landscape, Analyst Says

Advances in presbyopia treatment with LENZ Therapeutics' LNZ100. Clinically proven to enhance near-vision for up to 10 hours, it offers a promising alternative to reading glasses. Analysts predict a bright future with a Buy rating and $34 price target.

ABBV